(Q35095166)

6 August 2017

1 reference

title

Bradykinin receptors as a therapeutic target (English)

1 reference

6 August 2017

John Howl

1

1 reference

6 August 2017

Sarah J Payne

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Expert Opinion on Therapeutic Targets

6 August 2017

published in

1 reference

6 August 2017

volume

7

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

277-285

1 reference

A novel mechanism for bradykinin production at inflammatory sites. Diverse effects of a mixture of neutrophil elastase and mast cell tryptase versus tissue and plasma kallikreins on native and oxidized kininogens.

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Bradykinin antagonists: development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

The human B1 bradykinin receptor exhibits high ligand-independent, constitutive activity. Roles of residues in the fourth intracellular and third transmembrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Cloning and pharmacological characterization of a human bradykinin (BK-2) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Spontaneous human B2 bradykinin receptor activity determines the action of partial agonists as agonists or inverse agonists. Effect of basal desensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Bradykinin antagonists: present progress and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Metabolism-resistant bradykinin antagonists: development and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Regulation of leukocyte recruitment by polypeptides derived from high molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

B1 receptors as a new inflammatory target. Could this B the 1?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Kinin receptors in pain and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Effects of a nonpeptide bradykinin B2 receptor antagonist, FR167344, on different in vivo animal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Ramiprilat increases bradykinin outflow from isolated hearts of rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Targeting kinin B(1) receptor for therapeutic neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Bradykinin contributes to the vasodilator effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

The development of the bradykinin agonist labradimil as a means to increase the permeability of the blood-brain barrier: from concept to clinical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Pharmacokinetics of carboplatin administered in combination with the bradykinin agonist Cereport (RMP-7) for the treatment of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines by a "biased agonist" mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

A new class of bradykinin antagonists: synthesis and in vitro activity of bissuccinimidoalkane peptide dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

B1 Bradykinin Receptors and Carboxypeptidase M Are Both Upregulated in the Aorta of Pigs after LPS Infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.7.2.277

21 January 2018

Identifiers

DOI

10.1517/14728222.7.2.277

1 reference

6 August 2017

1 reference